Cell-specific FVIII expression in hemophilia A gene therapy to overcome immunological responses

被引：0
|
作者：
Merlin, S. [1 ]
Cannizzo, E. S. [1 ]
Bruscaggin, V [1 ]
Bellofatto, K. [1 ]
Follenzi, A. [1 ]
机构：
[1] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR411
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [1] Targeting FVIII expression to specific cell-types to overcome immunological responses for Hemophilia A gene therapy
    Merlin, S.
    Cannizzo, E. S.
    Bruscaggin, V.
    Follenzi, A.
    HUMAN GENE THERAPY, 2014, 25 (11) : A38 - A39
  • [2] Targeting FVIII Expression To Myeloid Cells To Overcome Immunological Responses To Gene Therapy for Hemophilia A
    Merlin, Simone
    Cannizzo, Stefania E.
    Feola, Maria
    Bruscaggin, Valentina
    Follenzi, Antonia
    MOLECULAR THERAPY, 2014, 22 : S305 - S305
  • [3] Transcriptional and post-transcriptional targeting of FVIII expression to overcome immunological responses to gene therapy for Hemophilia A
    Cannizzo, E. Stefania
    Merlin, S.
    Feola, M.
    Zanolini, D.
    Follenzi, A.
    HUMAN GENE THERAPY, 2013, 24 (12) : A50 - A50
  • [4] Transcriptional and post-transcriptional targeting of FVIII expression to overcome immunological responses to gene therapy for Hemophilia A
    Merlin, S.
    Cannizzo, E. S.
    Feola, M.
    Follenzi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 210 - 210
  • [5] TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL TARGETING OF FVIII EXPRESSION TO OVERCOME IMMUNOLOGICAL RESPONSES TO GENE THERAPY FOR HEMOPHILIA A
    Merlin, S.
    Cannizzo, E. S.
    Bruscaggin, V.
    Feola, M.
    Follenzi, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S119 - S120
  • [6] Transcriptional and Post-Transcriptional Regulation To Overcome Immunological Responses to Gene Therapy for Hemophilia A
    Cannizzo, Stefania E.
    Merlin, Simone
    Follenzi, Antonia
    MOLECULAR THERAPY, 2013, 21 : S121 - S122
  • [7] Targeted FVIII expression under the control of its native promoter for hemophilia A gene and cell therapy
    Zanolini, D.
    Merlin, S.
    Fama, R.
    Borroni, E.
    Bruscaggin, V.
    Zucchelli, S.
    Follenzi, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A147 - A147
  • [8] Targeted FVIII Expression Under the Control of Its Native Promoter for Hemophilia A Gene and Cell Therapy
    Fama, Rosella
    Merlin, Simone
    Borroni, Ester
    Bruscaggin, Valentina
    Zucchelli, Silvia
    Follenzi, Antonia
    MOLECULAR THERAPY, 2017, 25 (05) : 302 - 302
  • [9] Intravenous Lentiviral Gene Therapy for Hemophilia a: Endothelial-Specific Expression and Increased Glycosylation for Improved FVIII Function
    Gong, Jie
    Liu, Yuchen
    Zhou, Min
    Chang, Lung-Ji
    BLOOD, 2022, 140 : 10650 - 10651
  • [10] Targeting FVIII expression in endothelial and myeloid cells for hemophilia A gene therapy in mice
    Merlin, S.
    Cannizzo, E. S.
    Borroni, E.
    Bruscaggin, V.
    Valente, G.
    Prat, M.
    Arruda, V. R.
    Follenzi, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A154 - A154
12345